Story Navigation
-
Access to HealthcareAccess to HealthcareCancerCOVID-19OncologyWorking at NovartisClinical ResearchCancer didn’t stop for COVID-19
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Access to Healthcare -
Access to HealthcareCOVID-19Infectious DiseasesInnovationWorking at NovartisStreamlining systems to respond to COVID-19
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Access to Healthcare -
Access to HealthcareAccess to HealthcareAfricaGlobal Health PartnershipsSustainable DevelopmentDiabetesCollaboration is strengthening care for chronic illness in Ethiopia
Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.
Access to Healthcare -
Access to HealthcareAccess to HealthcareAfricaDisease AwarenessGlobal Health PartnershipsNovartis Social BusinessSocial CommitmentHelping people with sickle cell disease, a painful and life-threatening blood disorder
A collaboration in Ghana aims to expand early diagnosis and treatment of people with this inherited illness.
Access to Healthcare -
Access to HealthcareAccess to HealthcareData ScienceDigitalEmerging TechnologyGlobal Health PartnershipsAI is changing the face of healthcare
AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.
Access to Healthcare -
Access to HealthcareDisease EradicationInfectious DiseasesMalariaNovartis Malaria InitiativeNovartis Social BusinessAsian health experts call for final push to wipe out deadliest form of malaria
The most lethal strain could be eliminated by 2030, but major hurdles remain.
Access to Healthcare -
Access to HealthcareAccess to HealthcareChronic IllnessFuture of HealthcareNovartis AccessNovartis Social BusinessNovartis Access impact evaluation: progress update on our work with Boston University
Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
Access to Healthcare -
Access to HealthcareAccess to HealthcareChronic IllnessGlobal Health PartnershipsMobile DevicesReimagine MedicineImproving lives through community-based care
Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.
Access to Healthcare -
Access to HealthcareAccess to HealthcareNext Generation ScientistNovartis Institutes for BioMedical ResearchWorking at NovartisReimagine MedicineMeet Manuel Cobos, transplant surgeon and researcher
Follow Dr. Cobos as he works to provide a patient with a new liver and performs surgery using a tiny video camera.
Access to Healthcare -
Access to HealthcareAccess to HealthcareDisease EradicationMalariaNovartis Malaria InitiativeNovartis Social BusinessAfrican experts call for renewed global drive to beat malaria
Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
Access to Healthcare -
Access to HealthcareAccess to HealthcareMalariaNovartis Malaria InitiativeNovartis Social BusinessClinical TrialsMeet Martin Grobusch, malaria fighter
One man’s fascination with malaria helps fuel the search for new treatments.
Access to Healthcare -
Access to HealthcareAccess to HealthcareMalariaNovartis Malaria InitiativeNovartis Social BusinessDrug DevelopmentMalaria is still disrupting lives, despite progress
The disease hobbles families and economies.
Access to Healthcare
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- › Next page